Published April 1, 2022 | Version v1
Journal article Open

Association of ADIPOQ (rs 2241766) Gene Polymorphism with Type 2 Diabetes Mellitus Patients A Case-Control Study

  • 1. Department of Chemistry, College of Education, University of Al-Qadisiyah, Al-Diwaniyah – Iraq

Description

The adiponectin gene (ADIPOQ) is the main genetic determinant of plasma adiponectin amounts from (30 - 70%) of the inherited genetic components. Multiple nucleotide polymorphisms (SNPs) rs 2241766 for the ADIPOQ gene correlate with metabolic syndromes such as insulin resistance, abdominal obesity, impaired glucose tolerance, hyperlipidemia, hypertension, rapid glucose excess, and plasma adiponectin level. A polymorphism study was conducted based on PCR 2241766 in Al-Diwaniyah city in Iraq, and this study included (300) people aged (30-45) years who were distributed into two groups, the first group (G1) included (150) control, and the second group (G2) included (150) type 2 diabetes mellitus patients. The purpose of the current study was to reveal the ADIPOQ polymorphism and its role in the pathophysiology of type 2 diabetes mellitus. The overall genotype of the ADIPOQ rs2241766 gene was significantly different between the type 2 diabetes mellitus patients (G2) and control (G1) for the genotype GG (χ2 = 13.45, p-value = 0.002), G allele (χ2 = 10.324, p-value = 0.001), and TG & TT compared to the GG genotype (χ2 = 13.266, p-value = 0.0001). In conclusion, the results of the genotype and allele distribution of ADIPOQ rs2241766 gene in type 2 diabetes patients group showed that there is an association between ADIPOQ rs2241766 gene and type 2 diabetes mellitus.

Files

14-BCS-486-124.pdf

Files (682.2 kB)

Name Size Download all
md5:7b4951896d7d688fc1d363e711485594
682.2 kB Preview Download